NantPharma Email Format
Pharmaceutical ManufacturingIllinois, United States51-200 Employees
NantPharma develops and manufactures injectable pharmaceuticals, operating with an integrated platform designed to ensure high-quality products that support patient care. It currently produces crude heparin in a concentrated eluate form, derived from porcine intestinal mucosa sourced from slaughterhouses in the United States and Europe. This focus positions the company within the pharmaceutical manufacturing sector, emphasizing quality and reliability in injectable medicines. The organization is based in Illinois, with a Lincolnshire headquarters, a manufacturing facility in Oelwein, Iowa, and an R&D laboratory in the Chicagoland area; a listed address for Elk Grove Village, Illinois also appears among its locations. NantPharma serves clients in the pharmaceutical field that require development and production capabilities for injectable therapies. Its origins lie in a 2009 initiative led by Dr. Patrick Soon-Shiong within the NantWorks portfolio.